Carboplatin, Gemcitabine, and Mifepristone for Advanced Breast Cancer and Recurrent or Persistent Epithelial Ovarian Cancer
Phase of Trial: Phase I
Latest Information Update: 19 Sep 2018
At a glance
- Drugs Mifepristone (Primary) ; Carboplatin; Gemcitabine
- Indications Advanced breast cancer; Brain metastases; Fallopian tube cancer; Male breast cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 10 Sep 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 05 Dec 2017 Planned End Date changed from 1 Nov 2017 to 1 Jun 2018.